NCT05615181

Brief Summary

A monocentric Study to evaluate the french translation of Gothenburg Trismus Questionnaire (GTQ).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
310

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 22, 2020

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

November 7, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 14, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

September 8, 2025

Status Verified

September 1, 2025

Enrollment Period

2 years

First QC Date

November 7, 2022

Last Update Submit

September 5, 2025

Conditions

Trismus

Keywords

trismusPatient reported outcomesu Gothenburg Trismus Questionnaire

Outcome Measures

Primary Outcomes (1)

  • Gothenburg Trismus Questionnaire (GTQ)

    patient Reported Outcome measure: score 0-4 (0 means a better outcome, 4 means a worse outcome.)

    once at inclusion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient treated for trismus

You may qualify if:

  • Patient treated for trismus
  • Age ≥ 18 years old
  • Read, write and understand the French language

You may not qualify if:

  • Patient under guardianship, deprived of liberty, safeguard of justice
  • Refusal to participate in research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ch Valence

Valence, Drome, 26953, France

Location

MeSH Terms

Conditions

Trismus

Condition Hierarchy (Ancestors)

SpasmNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 7, 2022

First Posted

November 14, 2022

Study Start

December 22, 2020

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

September 8, 2025

Record last verified: 2025-09

Locations

FR(1)